|
|
 disability Information - January 8, 2009
| The consensus of the Centers for Disease Control and Prevention (CDC's) report: almost 80 percent of Americans aged 65 years and older have at least one chronic health disease (for instance, heart disease, diabetes, arthritis or depression). Nearly 40 percent of the elderly population have at least two chronic conditions. The CDC's report on "The State of Aging and Health in America 2007" was supported by The Merck Company Foundation in its fifth volume series of aging and health in America, including other regions of the world | | Authorities are investigating and also seeking out health options for a woman who caused a car crash due to an overflow of trash and garbage in her vehicle. The Cape Cod woman's car was so full of trash and shopping bags that police were sent to her home and found it not very livable. Officers at the scene investigating the crash found, "the entire interior of the vehicle was filled with all sorts of trash and rubbish, which covered the complete interior of the vehicle from floor to ceiling front and back | | The latest research reveals that long-term use of some of the most common drugs prescribed to tackle stomach acid problems or heartburn such as Nexium, Prevacid or Prilosec may be weakening people's bones. The University of Pennsylvania study also suggests that older people who take more of heartburn drugs or 'proton pump inhibitors' could be at greater risk of a broken hip | | The Food and Drug Administration has reportedly approved a new device for infants called Cool-Cap that can help prevent or reduce brain damage in infants whose oxygen level was diminished at the time of birth. The new chilling device is estimated to reduce the rates of death and disability among the estimated five-thousand to nine-thousand such children born each year | | The Food and Drug Administration (FDA) approved the drug Celebrex (Pfizer, Inc., NY, NY; generic: celecoxib) for a new use on Friday, in order to treat juvenile rheumatoid arthritis (JRA) for children as young as two years of age. The FDA's advisory panel had recommended the painkiller for this use back in November of 2006, with a vote of 15 to 1. The one opposing vote cited the lack of long-term, established data tracking the drug's safety for use in children. However, the 15 votes approving the recommendation claimed the risks involved outweighed the benefits | |
|
|